Long-Term Survival and Bipotent Terminal Differentiation of Human Mesenchymal Stem Cells (hMSC) in Combination with a Commercially Available Three-Dimensional Collagen Scaffold
Researchers working in the field of tissue engineering ideally combine autologous cells and biocompatible scaffolds to replace defect tissues/organs. Due to their differentiation capacity, mesenchym-derived stem cells, such as human mesenchymal stem cells (hMSC), are a promising autologous cell sour...
Main Authors: | S. Neuss, R. Stainforth, J. Salber, P. Schenck, M. Bovi, R. Knüchel, A. Perez-Bouza |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-08-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368908786576462 |
Similar Items
-
hMSC response to augmented CaP nanotopography
by: McLister, Robert
Published: (2016) -
Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
by: Xuegang Yuan, et al.
Published: (2019-05-01) -
Transcriptome analysis of MSC and MSC-derived osteoblasts on Resomer® LT706 and PCL: impact of biomaterial substrate on osteogenic differentiation.
by: Sabine Neuss, et al.
Published: (2011-01-01) -
Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice.
by: Silvia Mora-Lee, et al.
Published: (2012-01-01) -
Comparison of Hyclone and Biow: Effect to hMSC Proliferation, Morphology, and Osteogenic Differentiationest
by: Tania Saskianti, et al.
Published: (2013-01-01)